You obviously don't understand that all chemo drugs are toxic and that this guys comments are not based on fact yet as that data/report has not been released
I couldn't agree with you more. The guy from Stifel is an idiot - there is no way for him to know the results from the trial and posting anything about toxicity is BS. The real new will be out very soon.
Exelixis, Inc. (NASDAQ: EXEL) - Hold
"Data in NSCLC supports cabozanitinib activity but at the cost of potentially excessive toxicity. We believe data in this indication and others to be presented at ASCO, will support our contention that 60 mg is too intolerable for patients, which could bode poorly for the ongoing Phase 3 METEOR trial which employs this dose in relatively healthy RCC patients."
I didn't either - currently have 21k of them under $2/share. But based on what i'm seeing with this drug and the potential to have two new approved drugs with broad reaching treatments. What's the value of EXEL in a year - could easily be $15 - 20/share
The short weekly parabolics have been in place for almost a year without being tested. from a tech point of view bottom is likely in and should move higher
Man i just loved exercising my 1.5 May Calls. Bough for .25 cents back in DEC. Now i own 1500 more shares at 1.75 and forced someone to give me my shares. wonderful thing
mj5252...earning most certainly have a lot to do with price action. The earings were good they beat execution. This means the company is moving forward in a POSITIVE direction. Earning combined with the expecation of positive trial news is extremely positive. For the shorts and there are a ton - how do you think they feel right now. Earning are not meaningless...where would this stock be if earning met or barely disappointed. They matter!!!
Wow ...you're really grasping. I hope people aren't dumb enough to take you advice
Dude - you need to go to the clue store and by a big bag. This stock is up over 80% from JAN. What do you want it to do. All that was released this morning was fast track news. I much prefer this type of move now as opposed to what will happen when it gets FDA approval.
have you looked at the side effects of any drug that is taken. they have to list all possible indications. it it's going to extend your life, you'll take it.
seman- brilliant thought there buddy. did you read the press release. did you comprehend what this means. there is no ..i repeat no negative news. this stock was % short. knowing when to bail out of a stock due to either taking a loss or profit is all part of being a disciplined investor. this will not go back and fill the gap anytime soon.